These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29589299)

  • 1. Dissecting Oncogenic RTK Pathways in Colorectal Cancer Initiation and Progression.
    McManus S; Chababi W; Arsenault D; Dubois CM; Saucier C
    Methods Mol Biol; 2018; 1765():27-42. PubMed ID: 29589299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.
    Pomerleau V; Landry M; Bernier J; Vachon PH; Saucier C
    BMC Cancer; 2014 Apr; 14():240. PubMed ID: 24708867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic engagement of the Met receptor is sufficient to evoke angiogenic, tumorigenic, and metastatic activities in rat intestinal epithelial cells.
    Bernier J; Chababi W; Pomerleau V; Saucier C
    Am J Physiol Gastrointest Liver Physiol; 2010 Sep; 299(3):G677-86. PubMed ID: 20539003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance.
    Joosten SPJ; Spaargaren M; Clevers H; Pals ST
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188437. PubMed ID: 32976979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
    Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
    Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition.
    Tanahashi T; Osada S; Yamada A; Kato J; Yawata K; Mori R; Imai H; Sasaki Y; Saito S; Tanaka Y; Nonaka K; Yoshida K
    Int J Oncol; 2013 Feb; 42(2):556-64. PubMed ID: 23229794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
    Saucier C; Papavasiliou V; Palazzo A; Naujokas MA; Kremer R; Park M
    Oncogene; 2002 Mar; 21(12):1800-11. PubMed ID: 11896612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential therapeutic and prognostic impacts of the c-MET/HGF signaling pathway in colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Fazilat-Panah D; Hassanian SM; Shahidsales S; Khazaei M; Parizadeh SMR; Ghayour-Mobarhan M; Ferns GA; Avan A
    IUBMB Life; 2019 Jul; 71(7):802-811. PubMed ID: 31116909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
    Vincan E; Brabletz T; Faux MC; Ramsay RG
    Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The c-Met receptor: Implication for targeted therapies in colorectal cancer.
    Safaie Qamsari E; Safaei Ghaderi S; Zarei B; Dorostkar R; Bagheri S; Jadidi-Niaragh F; Somi MH; Yousefi M
    Tumour Biol; 2017 May; 39(5):1010428317699118. PubMed ID: 28459362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
    Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
    J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
    Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
    Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
    Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
    Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
    García-Vilas JA; Medina MÁ
    World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.